Letter to the Editor of The Washington Post Criticizing FDA for its Failure to Regulate Drug Manufacturing by Compounding Pharma

In a letter to the editor of The Washington Post, Public Citizen responded to the April 12 front-page article “FDA finds safety problems at specialized pharmacies.” The Food and Drug Administration must ensure that companies that engage in drug manufacturing under the guise of pharmacy compounding either scale down their operations or adhere to current federal regulations governing drug manufacturing.

The full letter can be viewed at http://www.washingtonpost.com/opinions/compounding-pharmacies-can-be-regulated-by-fda/2013/04/21/45299928-a6db-11e2-9e1c-bb0fb0c2edd9_story.html.